News
-
-
-
-
-
-
-
-
PRESS RELEASE
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Moderna receives approval in Japan for updated Spikevax vaccine targeting SARS-CoV-2 variant JN.1, aligning with WHO recommendations, to be part of Japan's national immunization program -
-